With new study, EBE and EFPIA urge EU Member States to implement five new policy recommendations to advance personalised medicine

At European Biopharmaceutical Enterprises (EBE), one of our top priorities has always been to advocate for better access to innovative personalised medicine to help deliver tangible health improvements for EU citizens. That’s why today we are calling on EU Member States to implement five new policy recommendations for personalised medicine from coherent prioritisation of personalised [...]